Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Kudelka AP, Levy T, Verschraegen CF, Edwards CL, Piamsomboon S, Termrungruanglert W, Freedman RS, Kaplan AL, Kieback DG, Meyers CA, Jaeckle KA, Loyer E, Steger M, Mante R, Mavligit G, Killian A, Tang RA, Gutterman JU, Kavanagh JJ. Kudelka AP, et al. Among authors: steger m. Clin Cancer Res. 1997 Sep;3(9):1501-5. Clin Cancer Res. 1997. PMID: 9815836 Clinical Trial.
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
Verschraegen CF, Gupta E, Loyer E, Kavanagh JJ, Kudelka AP, Freedman RS, Edwards CL, Harris N, Steger M, Steltz V, Giovanella BC, Stehlin JS. Verschraegen CF, et al. Among authors: steger m. Anticancer Drugs. 1999 Apr;10(4):375-83. doi: 10.1097/00001813-199904000-00005. Anticancer Drugs. 1999. PMID: 10378672 Clinical Trial.
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma.
Verschraegen CF, Sittisomwong T, Kudelka AP, Guedes Ed, Steger M, Nelson-Taylor T, Vincent M, Rogers R, Atkinson EN, Kavanagh JJ. Verschraegen CF, et al. Among authors: steger m. J Clin Oncol. 2000 Jul;18(14):2733-9. doi: 10.1200/JCO.2000.18.14.2733. J Clin Oncol. 2000. PMID: 10894873 Clinical Trial.
Bridging the Gap from Proteomics Technology to Clinical Application: Highlights from the 68th Benzon Foundation Symposium.
Albrecht V, Müller-Reif J, Nordmann TM, Mund A, Schweizer L, Geyer PE, Niu L, Wang J, Post F, Oeller M, Metousis A, Bach Nielsen A, Steger M, Wewer Albrechtsen NJ, Mann M. Albrecht V, et al. Among authors: steger m. Mol Cell Proteomics. 2024 Nov 8:100877. doi: 10.1016/j.mcpro.2024.100877. Online ahead of print. Mol Cell Proteomics. 2024. PMID: 39522756 Free article.
Natural proteome diversity links aneuploidy tolerance to protein turnover.
Muenzner J, Trébulle P, Agostini F, Zauber H, Messner CB, Steger M, Kilian C, Lau K, Barthel N, Lehmann A, Textoris-Taube K, Caudal E, Egger AS, Amari F, De Chiara M, Demichev V, Gossmann TI, Mülleder M, Liti G, Schacherer J, Selbach M, Berman J, Ralser M. Muenzner J, et al. Among authors: steger m. Nature. 2024 Jun;630(8015):149-157. doi: 10.1038/s41586-024-07442-9. Epub 2024 May 22. Nature. 2024. PMID: 38778096 Free PMC article.
149 results